Development of Novel or Improved Infertility Technologies (R61/R33)

The purpose of this grant is to support and facilitate multidisciplinary research approaches for the development or improvement of technologies, including drugs, devices, products, or clinical practices designed to improve fertility outcomes in patients dealing with infertility, particularly in the context of Assisted Reproductive Technologies (ART). 

Please remember! NIH will no longer issue awards (new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/ subcontracts

Funding: R61 $300,000 per year; R33 $471,000 per year 

Duration: 5 years total 

Research Authority due date: 15.10.25

LOI (encouraged) due date: 20.10.25

Full proposal due date: 20.11.25